Biography

Prof. Craig Stephen Atwood

Department of Medicine

University of Wisconsin, USA


Email: csa@medicine.wisc.edu


Qualifications

1993 Ph.D., University of Western Australia, Biochemistry
1984 B.Sc., University of Western Australia, Biochemistry


Publications (Selected)

  1. Butler, T., Tey, S. R., Galvin, J. E., Perry, G., Bowen, R. L., & Atwood, C. S. (2024). Endocrine Dyscrasia in the Etiology and Therapy of Alzheimer’s Disease. Journal of Alzheimer’s Disease, 101(3), 705-713.
  2. Rajabli, F., Benchek, P., Tosto, G., Kushch, N., Sha, J., Bazemore, K., ... & Lerner, A. (2023). Multi-ancestry genome-wide meta-analysis of 56,241 individuals identifies LRRC4C, LHX5-AS1 and nominates ancestry-specific loci PTPRK, GRB14, and KIAA0825 as novel risk loci for Alzheimer’s disease: the Alzheimer’s Disease Genetics Consortium. MedRxiv, 2023-07.
  3. Atwood, C. S., & Perry, G. (2023). Playing Russian Roulette with Alzheimer’s disease patients: Do the cognitive benefits of lecanemab outweigh the risk of edema, stroke and encephalitis?. Journal of Alzheimer's Disease, 92(3), 799-801.
  4. Wickramasuriya, N., Hawkins, R., Atwood, C., & Butler, T. (2022). The roles of GnRH in the human central nervous system. Hormones and behavior, 145, 105230.
  5. Butler, T., Glodzik, L., Wang, X. H., Xi, K., Li, Y., Pan, H., ... & Mozley, P. D. (2022). Positron Emission Tomography reveals age-associated hypothalamic microglial activation in women. Scientific Reports, 12(1), 13351.
  6. Liu, T., Bowen, R. L., Wilson, A. C., & Atwood, C. S. (2022). Estropause, sex hormones and metal homeostasis in the mouse brain. Frontiers in Neurology, 13, 841822.
  7. Butler, T., Glodzik, L., Wang, X. H., Xi, K., Li, Y., Pan, H., ... & Mozley, P. D. (2022). Greater hypothalamic microglial activation with aging in women as compared to men: potential relevance to sex and species differences in reproductive and biologic aging.
  8. Bellenguez, C., Küçükali, F., Jansen, I. E., Kleineidam, L., Moreno-Grau, S., Amin, N., ... & Goldhardt, O. (2022). New insights into the genetic etiology of Alzheimer’s disease and related dementias. Nature genetics, 54(4), 412-436.
  9. Heath, L., Earls, J. C., Magis, A. T., Kornilov, S. A., Lovejoy, J. C., Funk, C. C., ... & Price, N. D. (2022). Manifestations of Alzheimer’s disease genetic risk in the blood are evident in a multiomic analysis in healthy adults aged 18 to 90. Scientific reports, 12(1), 6117.
  10. Butler, T., Goldberg, J. D., Galvin, J. E., Maloney, T., Ravdin, L., Glodzik, L., ... & Atwood, C. S. (2021). Rationale, study design and implementation of the LUCINDA Trial: Leuprolide plus Cholinesterase Inhibition to reduce Neurologic Decline in Alzheimer's. Contemporary clinical trials, 107, 106488.
  11. Geddes, R. I., Kapoor, A., Hayashi, K., Rauh, R., Wehber, M., Bongers, Q., ... & Atwood, C. S. (2021). Hypogonadism induced by surgical stress and brain trauma is reversed by human chorionic gonadotropin in male rats: A potential therapy for surgical and TBI‐induced hypogonadism?. Endocrinology, diabetes & metabolism, 4(3), e00239.
  12. Butler, T., Atwood, C. S., Galvin, J. E., Maloney, T., Glodzik, L., de Leon, M. J., & Goldberg, J. D. (2020). The LUCINDA trial: Leuprolide+ cholinesterase inhibition to reduce neurologic decline in Alzheimer's: Human/Human trials: Other. Alzheimer's & Dementia, 16, e038780.
  13. Hayashi, K., Gonzales, T. K., Kapoor, A., Ziegler, T. E., Meethal, S. V., & Atwood, C. S. (2020). Development of classification models for the prediction of Alzheimer’s Disease utilizing circulating sex hormone ratios. Journal of Alzheimer's Disease, 76(3), 1029-1046.
  14. Reiman, E. M., Arboleda-Velasquez, J. F., Quiroz, Y. T., Huentelman, M. J., Beach, T. G., Caselli, R. J., ... & Jun, G. R. (2020). Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study. Nature communications, 11(1), 667.
  15. Ma, Y., Jun, G. R., Chung, J., Zhang, X., Kunkle, B. W., Naj, A. C., ... & Lunetta, K. L. (2019). CpG‐related SNPs in the MS4A region have a dose‐dependent effect on risk of late–onset Alzheimer disease. Aging Cell, 18(4), e12964.
  16. Kunkle, B. W., Grenier-Boley, B., Sims, R., Bis, J. C., Damotte, V., Naj, A. C., ... & Rotter, J. I. (2019). Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing. Nature genetics, 51(3), 414-430.
  17. Hu, Y., Li, M., Lu, Q., Weng, H., Wang, J., Zekavat, S. M., ... & Zhao, H. (2019). A statistical framework for cross-tissue transcriptome-wide association analysis. Nature genetics, 51(3), 568-576.
  18. Kunkle, B. W., Grenier-Boley, B., Sims, R., Bis, J. C., Damotte, V., Naj, A. C., ... & Rotter, J. I. (2019). Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing. Nature genetics, 51(3), 414-430.
  19. Alzheimer Disease Genetics Consortium. (2019). Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing. Nature genetics, 51(3), 414-430.
  20. Atwood, C. S., & Ekstein, S. F. (2019). Human versus non-human sex steroid use in hormone replacement therapies part 1: Preclinical data. Molecular and cellular endocrinology, 480, 12-35.
  21. Smith, M. A., Bowen, R. L., Nguyen, R. Q., Perry, G., Atwood, C. S., & Rimm, A. A. (2018). Putative gonadotropin-releasing hormone agonist therapy and dementia: an application of Medicare hospitalization claims data. Journal of Alzheimer's Disease, 63(4), 1269-1277.
  22. Atwood, C. S., Huang, X., Moir, R. D., Tanzi, R. E., & Bush, A. I. (2018). Role of free radicals and metal ions in the pathogenesis of Alzheimer’s disease. Metal ions in biological systems, 309-364.
  23. Kunkle, B. W., Grenier-Boley, B., Sims, R., Bis, J. C., Naj, A. C., Boland, A., ... & Hanon, O. (2018). Meta-analysis of genetic association with diagnosed Alzheimer’s disease identifies novel risk loci and implicates Abeta, Tau, immunity and lipid processing. BioRxiv, 294629.
  24. Sims, R., Van Der Lee, S. J., Naj, A. C., Bellenguez, C., Badarinarayan, N., Jakobsdottir, J., ... & Daniilidou, M. (2017). Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. Nature genetics, 49(9), 1373-1384.
  25. Sims, R., Van Der Lee, S. J., Naj, A. C., Bellenguez, C., Badarinarayan, N., Jakobsdottir, J., ... & Daniilidou, M. (2017). Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. Nature genetics, 49(9), 1373-1384.


Profile Details

https://www.adrc.wisc.edu/craig-s-atwood-phd

https://scholar.google.com/citations?user=eQYh0q8AAAAJ&hl=en

https://www.researchgate.net/profile/Craig-Atwood

https://www.webofscience.com/wos/author/record/2459689


Free SCIRP Newsletters
Copyright © 2006-2025 Scientific Research Publishing Inc. All Rights Reserved.
Top